87626-30-0

Basic information

• Product Name: rel-(2R,6S,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,6-tetrahydro-2,6-methano-3-benzazocine
• CAS NO: 87626-30-0
• Molecular Weight: 393.526
• Mol File: 87626-30-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: rel-(2R,6S,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,6-tetrahydro-2,6-methano-3-benzazocine(CAS DataBase Reference)
• NIST Chemistry Reference: rel-(2R,6S,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,6-tetrahydro-2,6-methano-3-benzazocine(87626-30-0)
• EPA Substance Registry System: rel-(2R,6S,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,6-tetrahydro-2,6-methano-3-benzazocine(87626-30-0)

Safety Data

• Hazardous Substances Data: 87626-30-0(Hazardous Substances Data)

Upstream product

• 6921-34-2 benzylmagnesium chloride 
• 42529-29-3 (6R,11R)-3,6,11-Trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine 
• 23909-63-9 rel-(2R,6R,11S)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine 
• 49822-16-4 (6R,11R)-3,6,11-Trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine; hydrochloride 
• 87626-28-6 rel-(2R,6R,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenylacetyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine 
• 6283-41-6 1,3,4-trimethylpyridinium iodide 
• 87626-26-4 2-benzyl-1,3,4-trimethyl-1,2,5,6-tetrahydropyridine 
• 87680-51-1 rel-(2R,6R,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine 

Downstream Products

• 87680-51-1 rel-(2R,6R,11S)-6,11-dimethyl-3-(3,4,5-trimethoxyphenethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine 

Relevant articles and documents

Benzomorphan related compounds. XVII. Oxidative cyclization of N-arylethyl-6,7-benzomorphan

The synthesis of two new bridged polycyclic systems (I and II), possessing a rigid N-arylethylbenzomorphan structure, by mercuric acetate cyclization of the corresponding seco derivatives (IV and VI, respectively) is described. The relative configuration of these compounds and the preferred indolo[2,3-a]- or benzo[a]quinolizidine conformation is assigned.